Evaluation of Safety and Parameters of Application Technique

Monitoring of Expected Parameters of the Application Technique and Safety of the Therapy

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01516242

Enrollment

4819

Registered

2012-01-24

Start date

2006-10-31

Completion date

2007-12-31

Last updated

2016-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delivery Systems, Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Brief summary

This study is conducted in Europe. The aim of the study is to monitor patients changing therapy from syringe to insulin delivery system as prescribed by the treating physician in Slovakia.

Interventions

OTHERNo treatment given

Collection of data about patients with type 1 diabetes or type 2 diabetes treated with insulin changing their insulin administration from syringe to a insulin delivery system based on completion of questionaire

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Diabetes mellitus (type 1 or type 2) * Treated with insulin

Design outcomes

Primary

Measure	Time frame
Number of insulin applications (punctures)	—
Reasons leading to change of the therapy	—
Patient satisfaction with NovoPen® 4 insulin delivery system	—

Secondary

Measure	Time frame
Adverse reactions	—
Hypoglycaemia	—

Countries

Slovakia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026